Have a feature idea you'd love to see implemented?
Let us know!
ONVO Organovo Holdings Inc
Price (delayed)
$0.4579
Market cap
$7.04M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.38
Enterprise value
$1.99M
Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's
Highlights
The EPS has increased by 33% year-on-year and by 14% since the previous quarter
ONVO's debt is down by 25% year-on-year and by 8% since the previous quarter
ONVO's quick ratio has soared by 90% from the previous quarter but it is down by 50% YoY
The equity has soared by 85% since the previous quarter but it has declined by 43% year-on-year
ONVO's gross profit has dropped by 84% year-on-year and by 35% since the previous quarter
The revenue has plunged by 84% YoY and by 33% from the previous quarter
Key stats
What are the main financial stats of ONVO
Market
Valuations
Earnings
Shares outstanding
15.36M
Market cap
$7.04M
Enterprise value
$1.99M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.99
Price to sales (P/S)
91.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.26
Revenue
$73,000
EBIT
-$13.99M
EBITDA
-$13.7M
Free cash flow
-$12.35M
Per share
Balance sheet
Liquidity
EPS
-$1.38
Free cash flow per share
-$0.84
Book value per share
$0.46
Revenue per share
$0
TBVPS
$0.65
Total assets
$9.47M
Total liabilities
$2.81M
Debt
$1.29M
Equity
$6.66M
Working capital
$5.25M
Debt to equity
0.19
Current ratio
3.58
Quick ratio
3.14
Net debt/EBITDA
0.37
Margins
Efficiency
Dividend
EBITDA margin
-18,769.9%
Gross margin
97.3%
Net margin
-19,160.3%
Operating margin
-19,557.5%
Return on assets
-156%
Return on equity
-224.7%
Return on invested capital
-470.9%
Return on capital employed
-188%
Return on sales
-19,157.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ONVO stock price
How has the Organovo Holdings stock price performed over time
Intraday
1.53%
1 week
-3.6%
1 month
-16.44%
1 year
-62.16%
YTD
-58.75%
QTD
-10.04%
Financial performance
How have Organovo Holdings's revenue and profit performed over time
Revenue
$73,000
Gross profit
$71,000
Operating income
-$14.28M
Net income
-$13.99M
Gross margin
97.3%
Net margin
-19,160.3%
ONVO's gross profit has dropped by 84% year-on-year and by 35% since the previous quarter
The revenue has plunged by 84% YoY and by 33% from the previous quarter
ONVO's net margin is down by 42% since the previous quarter
The operating margin has declined by 41% since the previous quarter
Growth
What is Organovo Holdings's growth rate over time
Valuation
What is Organovo Holdings stock price valuation
P/E
N/A
P/B
0.99
P/S
91.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.26
The EPS has increased by 33% year-on-year and by 14% since the previous quarter
The equity has soared by 85% since the previous quarter but it has declined by 43% year-on-year
The stock's price to book (P/B) is 46% less than its last 4 quarters average of 1.8 and 43% less than its 5-year quarterly average of 1.7
The revenue has plunged by 84% YoY and by 33% from the previous quarter
The P/S is 17% above the last 4 quarters average of 77.7
Efficiency
How efficient is Organovo Holdings business performance
The ROE has plunged by 131% YoY and by 15% from the previous quarter
ONVO's return on assets has dropped by 90% year-on-year and by 9% since the previous quarter
ONVO's return on invested capital has dropped by 77% year-on-year and by 7% since the previous quarter
The ROS has declined by 42% since the previous quarter
Dividends
What is ONVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ONVO.
Financial health
How did Organovo Holdings financials performed over time
ONVO's quick ratio has soared by 90% from the previous quarter but it is down by 50% YoY
ONVO's current ratio has soared by 69% QoQ but it is down by 46% YoY
ONVO's debt is 81% smaller than its equity
The equity has soared by 85% since the previous quarter but it has declined by 43% year-on-year
The debt to equity has plunged by 51% from the previous quarter but it has grown by 36% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.